Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Paragon Care Limited ( (AU:PGC) ) has issued an update.
Paragon Care Limited held its 2025 Annual General Meeting, where all resolutions, including the adoption of the remuneration report, election and re-election of directors, adoption of an omnibus equity plan, and issuance of performance rights to the CEO, were carried with overwhelming support. This indicates strong shareholder confidence in the company’s leadership and strategic direction, potentially strengthening its position in the healthcare industry.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, providing medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturing Blood Bank diagnostic reagents. The company serves healthcare markets in Australia, New Zealand, and Asia.
Average Trading Volume: 569,080
Technical Sentiment Signal: Sell
Current Market Cap: A$521.4M
For detailed information about PGC stock, go to TipRanks’ Stock Analysis page.